ProMIS Neurosciences, Inc.
PMN
$0.52
$0.0193.79%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 2.78M | -563.40K | -12.20M | -11.89M | -13.21M |
| Total Depreciation and Amortization | -- | 18.00K | 18.30K | 19.50K | 21.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -18.23M | -13.49M | -217.70K | -688.50K | -597.00K |
| Change in Net Operating Assets | -11.73M | -8.19M | -5.53M | -6.02M | 2.94M |
| Cash from Operations | -27.18M | -22.23M | -17.93M | -18.57M | -10.84M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -700.00 | -1.30K | -1.30K | -1.30K | -1.30K |
| Cash from Investing | -700.00 | -1.30K | -1.30K | -1.30K | -1.30K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 27.88M | 27.41M | 18.45M | 18.45M | 18.26M |
| Repurchase of Common Stock | -- | -510.60K | -510.60K | -510.60K | -510.60K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 27.88M | 26.90M | 17.94M | 17.94M | 17.75M |
| Foreign Exchange rate Adjustments | -- | 0.00 | -237.30K | -199.10K | -181.40K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 693.00K | 4.67M | -230.20K | -834.80K | 6.72M |